Year: 2018
Type: article
Abstract: > See the associated articles on pages [1187][1] and [1195][2]. Differentiated thyroid cancer is a fascinating disease—it is both frustrating and heartening to treat. As eloquently pointed out by Tuttle in this issue of The Journal of Nuclear Medicine ([1][3]), “[M]ost patients with low-risk
Source: Journal of Nuclear Medicine
Author: Daniel A. Pryma
Institution: University of Pennsylvania
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2809326544
